Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adjuvant treatment for adults and children age 12 and older with stage IIB or IIC melanoma after complete resection.
LAMPGEN ANALYSIS
Why it matters
The action broadens postoperative immunotherapy to specified high-risk stage II melanoma populations.
What research teams should watch
Verify surgical pathology, stage and resection completeness before applying the historical eligibility criteria.
PRIMARY RECORDS